Ethical challenges of clinical trials with a repurposed drug in outbreaks

Medicine, Health Care and Philosophy 26 (2):233-241 (2023)
  Copy   BIBTEX

Abstract

Drug repurposing is a strategy of identifying new potential uses for already existing drugs. Many researchers adopted this method to identify treatment or prevention during the COVID-19 pandemic. However, despite the considerable number of repurposed drugs that were evaluated, only some of them were labeled for new indications. In this article, we present the case of amantadine, a drug commonly used in neurology that attracted new attention during the COVID-19 outbreak. This example illustrates some of the ethical challenges associated with the launch of clinical trials to evaluate already approved drugs. In our discussion, we follow the ethics framework for prioritization of COVID-19 clinical trials proposed by Michelle N Meyer and colleagues (2021). We focus on four criteria: social value, scientific validity, feasibility, and consolidation/collaboration. We claim that launching amantadine trials was ethically justified. Although the scientific value was anticipated to be low, unusually, the social value was expected to be high. This was because of significant social interest in the drug. In our view, this strongly supports the need for evidence to justify why the drug should not be prescribed or privately accessed by interested parties. Otherwise, a lack of evidence-based argument could enhance its uncontrolled use. With this paper, we join the discussion on the lessons learned from the pandemic. Our findings will help to improve future efforts to decide on the launch of clinical trials on approved drugs when dealing with the widespread off-label use of the drug.

Links

PhilArchive



    Upload a copy of this work     Papers currently archived: 90,616

External links

Setup an account with your affiliations in order to access resources via your University's proxy server

Through your library

Similar books and articles

Clinical Ethics Consultation: Second International Summit.[author unknown] - 2004 - Medicine, Health Care and Philosophy 7 (2):237-238.
Clinical Ethics Consultation: First International Assessment.[author unknown] - 2004 - Medicine, Health Care and Philosophy 5 (3):327-327.
Clinical Ethics Consultation: 2. International Summit.[author unknown] - 2004 - Medicine, Health Care and Philosophy 7 (3):363-364.
Research as development: biomedical research, ethics, and collaboration in Sri Lanka.Salla Sariola - 2019 - Ithaca: Cornell University Press. Edited by Bob Simpson.
Abstracts for ESPMH conference ‘epistemology and medicine’.[author unknown] - 2004 - Medicine, Health Care and Philosophy 2 (1):81-109.
Metaphors in medicine.Henk ten Have & Bert Gordijn - 2022 - Medicine, Health Care and Philosophy 25 (4):577-578.

Analytics

Added to PP
2023-03-09

Downloads
4 (#1,426,245)

6 months
1 (#1,040,386)

Historical graph of downloads
How can I increase my downloads?